Nicotine Therapy Sampling to Induce Quit Attempts Among Smokers Unmotivated to Quit: A Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Rates of smoking cessation have not changed in a decade, accentuating the need for novel approaches to prompt quit attempts. METHODS: Within a nationwide randomized clinical trial (N = 849) to induce further quit attempts and cessation, smokers currently unmotivated to quit were randomized to a practice quit attempt (PQA) alone or to nicotine replacement therapy (hereafter referred to as nicotine therapy), sampling within the context of a PQA. Following a 6-week intervention period, participants were followed up for 6 months to assess outcomes. The PQA intervention was designed to increase motivation, confidence, and coping skills. The combination of a PQA plus nicotine therapy sampling added samples of nicotine lozenges to enhance attitudes toward pharmacotherapy and to promote the use of additional cessation resources. Primary outcomes included the incidence of any ever occurring self-defined quit attempt and 24-hour quit attempt. Secondary measures included 7-day point prevalence abstinence at any time during the study (ie, floating abstinence) and at the final follow-up assessment. RESULTS: Compared with PQA intervention, nicotine therapy sampling was associated with a significantly higher incidence of any quit attempt (49% vs 40%; relative risk [RR], 1.2; 95% CI, 1.1-1.4) and any 24-hour quit attempt (43% vs 34%; 1.3; 1.1-1.5). Nicotine therapy sampling was marginally more likely to promote floating abstinence (19% vs 15%; RR, 1.3; 95% CI, 1.0-1.7); 6-month point prevalence abstinence rates were no different between groups (16% vs 14%; 1.2; 0.9-1.6). CONCLUSION: Nicotine therapy sampling during a PQA represents a novel strategy to motivate smokers to make a quit attempt. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00706979.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · cited 1×
“There were no statistically significant differences between the treatment groups on any baseline measure (Table 1).(38)”
Physician advice for smoking cessation
Stead, L. F., Buitrago, D., Preciado, N., Sanchez, G., Hartmann-Boyce, J., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000165.pub4 · Cited by 1,955
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800 · cited 1×
“cluded, as it seems unnecessary with minimal interventions that incur few experimenter demand characteristics.(8,32)”
Effect of smoke-free workplaces on smoking behaviour: systematic review
Fichtenberg, C. M., & Glantz, S. A. (2002) · BMJ · doi:10.1136/bmj.325.7357.188 · Cited by 1,072
Distress tolerance and early smoking lapse
Brown, R. A., Lejuez, C. W., Kahler, C. W., Strong, D. R., & Zvolensky, M. J. (2005) · Clinical Psychology Review · doi:10.1016/j.cpr.2005.05.003 · Cited by 322
Does smoking reduction increase future cessation and decrease disease risk? A qualitative review
Hughes, J., & Carpenter, M. (2006) · Nicotine & Tobacco Research · doi:10.1080/14622200600789726 · Cited by 238
Self-citationCarpenter, M. J., Alberg, A. J., Gray, K. M., & Saladin, M. E. (2010) · Clinical Trials · doi:10.1177/1740774510361533 · Cited by 41 · cited 1×
“Trial methods and a detailed rationale for the study design have been reported elsewhere.(29) In this randomized 2-group study design, smokers who were unmotivated to quit were assigned (1) to a PQA alone or (2) to NT sampling within the context of a PQA.”
Self-citationFix, B. V., Hyland, A., Rivard, C., McNeill, A., Fong, G. T., Borland, R., Hammond, D., & Cummings, K. M. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8010222 · Cited by 35
Cited by
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Nicotine replacement therapy versus control for smoking cessation
Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub5 · Cited by 697
2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment
Barua, R. S., Rigotti, N. A., Benowitz, N. L., Cummings, K. M., Jazayeri, M.-A., Morris, P. B., Ratchford, E. V., Sarna, L., Stecker, E. C., & Wiggins, B. S. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.027 · Cited by 353
Lindson, N., Chepkin, S. C., Ye, W., Fanshawe, T. R., Bullen, C., & Hartmann-Boyce, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013308 · Cited by 254
A naturalistic, randomized pilot trial of e-cigarettes: uptake, exposure, and behavioral effects.
Carpenter, M. J., Heckman, B. W., Wahlquist, A. E., Wagener, T. L., Goniewicz, M. L., Gray, K. M., Froeliger, B., & Cummings, K. M. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0460 · Cited by 93
“Other, more active control groups might also be considered for future research, including: comparing ENDS sampling to provision of quit advice/materials, or perhaps samples of NRTs. Finally, EMA compliancewasmodest, somewhat dampening our rigor to assess daily fluctuations in use.”
BackgroundSelf-citation
Metadata
- Authors
- Carpenter, M. J.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2011-11-28
- Volume
- 171
- Issue
- 21
- Pages
- 1901
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2084408370
- Cited by
- 136
- References
- 8
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.